Effect of dose rate on pulmonary toxicity in patients with hematolymphoid malignancies undergoing total body irradiation

Radiation Oncology
Dong-Yun KimHyun-Cheol Kang

Abstract

This study evaluated the effect of radiation dose rate in patients with hematolymphoid malignancies undergoing myeloablative conditioning with total body irradiation (TBI), for hematopoietic stem cell transplantation. The incidence of pulmonary toxicity (PT) and treatment efficacy were compared between the conventional (≥ 6 cGy/min) and reduced dose rate (< 6 cGy/min). Seventy-seven patients receiving once-daily TBI between 2000 and 2016 were reviewed. We compared the cumulative rate of PT, overall survival (OS), relapse, and transplantation-related mortality (TRM) between conventional (n = 54) and reduced (n = 23) groups. Factors associated with PT were assessed in the presence of competing risks. The median follow-up time was 40.7 months, and PT occurred in 50 patients (64.9%). On multivariate analyses, the groups classified by the dose rate (P = 0.010), total dose (P = 0.025), and conditioning regimen (P = 0.029) were significant factors for the development of PT. OS was significantly reduced when PT occurred (P < 0.001). However, the OS, relapse, and TRM were not different between the two groups. In summary, about two-thirds of the patients undergoing daily TBI experienced PT, which affected OS. Therefore, reducing the dose...Continue Reading

References

Feb 1, 1986·Annals of Internal Medicine·R S WeinerA A Rimm
Jul 1, 1983·International Journal of Radiation Oncology, Biology, Physics·A BarrettR L Powles
Feb 1, 1983·International Journal of Radiation Oncology, Biology, Physics·M H DepledgeR L Powles
Jun 1, 1993·The American Review of Respiratory Disease·S W Crawford, R C Hackman
Jan 1, 1996·International Journal of Radiation Oncology, Biology, Physics·A SafwatJ Overgaard
Apr 28, 2004·The Tohoku Journal of Experimental Medicine·Murat BeyzadeogluYucel Pak
May 20, 2004·British Journal of Cancer·S A Carruthers, M M Wallington
Apr 7, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jason W ChienJoan G Clark
Oct 4, 2005·International Journal of Radiation Oncology, Biology, Physics·Sagus SampathJeffrey Wong
Feb 26, 2008·Gastroenterology·Murat TorunerLaurence J Egan
May 15, 2010·Infectious Disease Clinics of North America·John R WingardJohn W Hiemenz
Oct 12, 2010·International Journal of Radiation Oncology, Biology, Physics·Chris R KelseyLawrence B Marks
Sep 10, 2011·Journal of Radiation Research·Hiromi IzawaKeisuke Sasai
Jan 22, 2013·American Journal of Clinical Oncology·Suzanne L WoldenUNKNOWN American Society for Radiation Oncology
Dec 11, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mitchell SabloffWael Saber
Jan 9, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Johan TörlénJonas Mattsson

❮ Previous
Next ❯

Citations

Jul 2, 2021·Advances in Radiation Oncology·Richard PearlmanMichael Dominello

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage

Software Mentioned

Stata
MP

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.